The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres

Emily Stephenson, Gary Reynolds, Rachel A. Botting, Fernando J. Calero‐Nieto, Michael D. Morgan, Zewen Kelvin Tuong, Karsten Bach, Waradon Sungnak, Kaylee B. Worlock, Masahiro Yoshida, Natsuhiko Kumasaka, Katarzyna Kania, Justin Engelbert, Bayanne Olabi, Jarmila Stremenova Spegarova, Nicola K. Wilson, Nicole Mende, Laura Jardine, Louis Gardner, Issac Goh, Dave Horsfall, Jim McGrath, Simone Webb, Michael Mather, Rik G.h. Lindeboom, Emma Dann, Ni Huang, Krzysztof Polański, Elena Prigmore, Florian Gothe, Jonathan Scott, Rebecca Payne, Kenneth F. Baker, Aidan T. Hanrath, Ina Cd Schim van der Loeff, Andrew Barr, Amada Sanchez-Gonzalez, Laura Bergamaschi, Federica Mescia, Josephine L. Barnes, Eliz Kilich, Angus de Wilton, Anita Saigal, Aarash Saleh, Sam M. Janes, Claire M. Smith, Nusayhah Hudaa Gopee, Caroline Wilson, Paul Coupland, Jonathan Coxhead, Vladimir Yu Kiselev, Stijn van Dongen, Jaume Bacardit, Hamish W. King, Anthony Rostron, Angela Simpson, Sophie Hambleton, Elisa Laurenti, Paul Lyons, Kerstin B. Meyer, Marko Nikolić, C.j. Duncan, Kenneth Smith, Sarah A. Teichmann, Menna R. Clatworthy, John C. Marioni, Berthold Göttgens, Muzlifah HaniffamedRxiv 2021 · DOI

Abstract

The COVID-19 pandemic, caused by SARS-CoV-2, has resulted in significant global morbidity and mortality. To characterize the systemic host immune response, this study performed single-cell RNA-sequencing coupled with cell surface protein analysis on over 800,000 peripheral blood mononuclear cells (PBMCs) from a cohort of 130 patients. Spanning the clinical spectrum from asymptomatic to critical, and integrated across three UK centers, the study identifies unique cellular states and "emergency" hematopoietic pathways. Key findings include a novel monocyte state that replenishes alveolar macrophages, early priming of megakaryopoiesis in stem cells, and a distinct shift from IgA to IgG plasmablast dominance as disease severity increases. This high-resolution atlas serves as a template for multi-omic data integration and a resource for understanding the acute immune response to SARS-CoV-2.

Introduction

While the broad inflammatory signatures of COVID-19 are well-documented, the high-resolution coordination between different immune compartments—myeloid, lymphoid, and progenitor cells—remained poorly understood. Previous studies were often limited by small sample sizes or single-center biases. This multi-center study addresses these gaps by providing a comprehensive map of the systemic immune response across the full spectrum of clinical outcomes.

Methodology and Data Integration

The research team employed a "multi-omic" single-cell approach to analyze PBMCs from 130 patients (143 samples). The methodology included:

  • scRNA-seq & CITE-seq: Simultaneous sequencing of full transcriptomes and quantification of 188 cell surface proteins.
  • V(D)J Sequencing: Mapping the antigen receptor repertoires of T and B lymphocytes.
  • Cross-Center Integration: The Harmony algorithm was used to integrate data from Newcastle, Cambridge, and London, ensuring results were not biased by local processing differences.
  • Comparative Controls: The cohort was compared against healthy volunteers, patients with non-COVID severe respiratory illnesses, and individuals administered intravenous lipopolysaccharide (IV-LPS) to model acute systemic inflammation.

Key Insights into the Myeloid Response

The study identified novel cell states and interactions that link peripheral blood changes to lung pathology:

The Monocyte-Platelet Bridge

Researchers discovered a specific non-classical monocyte state ($C1QA/B/C^+ CD16^+$) that sequesters platelets. These cells show high transcriptional similarity to lung macrophages, suggesting they are the primary recruits sent from the blood to replenish the alveolar macrophage pool in damaged lung tissue.

Emergency Megakaryopoiesis

Even in asymptomatic patients, the study found a "priming" of hematopoietic stem cells toward megakaryopoiesis (platelet production). In symptomatic cases, this escalates into an expansion of megakaryocyte-primed progenitors in the blood—a sign of the bone marrow working overtime to compensate for systemic platelet consumption.

Adaptive Immune Dynamics and Severity

The transition from mild to severe disease is marked by significant shifts in the T and B cell compartments:

  • B-Cell Severity Switch: Asymptomatic individuals show an increase in IgA-secreting plasmablasts, likely providing mucosal protection. As severity increases, the system switches to IgG-secreting plasmablasts and plasma cells. This is accompanied by higher "BCR sharing" (convergent antibody responses), which may indicate a more stereotyped but less flexible response.
  • T-Cell Imbalance: Severe disease is characterized by an over-expansion of short-lived effector CD8+ T cells and a reduction in clonally expanded memory T cells. This suggests that in critical cases, the immune system prioritizes immediate, potentially tissue-damaging cytotoxicity over long-term protective immunity.

Systemic Signatures and Results

The integrated analysis identified 18 major cell subsets and 27 sub-states. A key finding was the upregulation of $IFNAR2$ across almost all circulating cell types in COVID-19 patients, a signature notably absent in the IV-LPS controls, marking it as a specific viral response. Additionally, cytokines such as CCL4, CXCL10, IL7, and IL1A were identified as primary markers of severe and critical disease. Interestingly, female patients exhibited higher BCR mutation levels, which may correlate with the generally better clinical outcomes observed in women.

Conclusion

This study provides one of the most detailed maps of the immune response to COVID-19 to date. By identifying specific cellular drivers of inflammation and lung repair, it offers a foundation for future therapeutic interventions. The authors have made the entire dataset available via an interactive web portal at covid19cellatlas.org, providing a massive resource for the global research community to further investigate the mechanisms of COVID-19 pathogenesis.

Summary updated

Abstract

Abstract The COVID-19 pandemic, caused by SARS coronavirus 2 (SARS-CoV-2), has resulted in excess morbidity and mortality as well as economic decline. To characterise the systemic host immune response to SARS-CoV-2, we performed single-cell RNA-sequencing coupled with analysis of cell surface proteins, providing molecular profiling of over 800,000 peripheral blood mononuclear cells from a cohort of 130 patients with COVID-19. Our cohort, from three UK centres, spans the spectrum of clinical presentations and disease severities ranging from asymptomatic to critical. Three control groups were included: healthy volunteers, patients suffering from a non-COVID-19 severe respiratory illness and healthy individuals administered with intravenous lipopolysaccharide to model an acute inflammatory response. Full single cell transcriptomes coupled with quantification of 188 cell surface proteins, and T and B lymphocyte antigen receptor repertoires have provided several insights into COVID-19: 1. a new non-classical monocyte state that sequesters platelets and replenishes the alveolar macrophage pool; 2. platelet activation accompanied by early priming towards megakaryopoiesis in immature haematopoietic stem/progenitor cells and expansion of megakaryocyte-primed progenitors; 3. increased clonally expanded CD8 + effector:effector memory T cells, and proliferating CD4 + and CD8 + T cells in patients with more severe disease; and 4. relative increase of IgA plasmablasts in asymptomatic stages that switches to expansion of IgG plasmablasts and plasma cells, accompanied with higher incidence of BCR sharing, as disease severity increases. All data and analysis results are available for interrogation and data mining through an intuitive web portal. Together, these data detail the cellular processes present in peripheral blood during an acute immune response to COVID-19, and serve as a template for multi-omic single cell data integration across multiple centers to rapidly build powerful resources to help combat diseases such as COVID-19.
BibTeX
@misc{stephenson2021cellular,
  author = {Emily Stephenson and Gary Reynolds and Rachel A. Botting and Fernando J. Calero‐Nieto and Michael D. Morgan and Zewen Kelvin Tuong and Karsten Bach and Waradon Sungnak and Kaylee B. Worlock and Masahiro Yoshida and Natsuhiko Kumasaka and Katarzyna Kania and Justin Engelbert and Bayanne Olabi and Jarmila Stremenova Spegarova and Nicola K. Wilson and Nicole Mende and Laura Jardine and Louis Gardner and Issac Goh and Dave Horsfall and Jim McGrath and Simone Webb and Michael Mather and Rik G.H. Lindeboom and Emma Dann and Ni Huang and Krzysztof Polański and Elena Prigmore and Florian Gothe and Jonathan Scott and Rebecca Payne and Kenneth F. Baker and Aidan T. Hanrath and Ina CD Schim van der Loeff and Andrew Barr and Amada Sanchez-Gonzalez and Laura Bergamaschi and Federica Mescia and Josephine L. Barnes and Eliz Kilich and Angus de Wilton and Anita Saigal and Aarash Saleh and Sam M. Janes and Claire M. Smith and Nusayhah Hudaa Gopee and Caroline Wilson and Paul Coupland and Jonathan Coxhead and Vladimir Yu Kiselev and Stijn van Dongen and Jaume Bacardit and Hamish W. King and Anthony Rostron and Angela Simpson and Sophie Hambleton and Elisa Laurenti and Paul Lyons and Kerstin B. Meyer and Marko Nikolić and C.J. Duncan and Kenneth Smith and Sarah A. Teichmann and Menna R. Clatworthy and John C. Marioni and Berthold Göttgens and Muzlifah Haniffa},
  title = {{The cellular immune response to COVID-19 deciphered by single cell multi-omics across three UK centres}},
  year = {2021},
  doi = {10.1101/2021.01.13.21249725},
  howpublished = {medRxiv},
}
Figure